Skip to main content

Published locations for Venetoclax achieves responses in CLL refractory to ibrutinib, idelalisib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Venetoclax achieves responses in CLL refractory to ibrutinib, idelalisib

User login

  • Reset your password
  • /content/venetoclax-achieves-responses-cll-refractory-ibrutinib-idelalisib
  • /hematologynews/article/109193/cll/venetoclax-achieves-responses-cll-refractory-ibrutinib-idelalisib
  • /oncologypractice/article/109193/cll/venetoclax-achieves-responses-cll-refractory-ibrutinib
  • /hematology-oncology/article/109193/cll/venetoclax-achieves-responses-cll-refractory-ibrutinib
  • /b-cell-lymphoma-icymi/article/109193/cll/venetoclax-achieves-responses-cll-refractory-ibrutinib